MOUNTAIN VIEW, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, announced today that it will present at the upcoming Noble Financial Fourth Annual Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, NV. Shawn O'Connor, Chairman and Chief Executive Officer and Will Fredrick, Senior Vice President and Chief Financial Officer will discuss the Company's business strategy and historical financial performance at 11:00 a.m. Pacific Time on Tuesday, August 19th.
A live audio webcast of Pharsight's presentation may be accessed through the Company's website at www.pharsight.com. An archived replay of the presentation will be available after the live presentation, and can also be accessed at www.pharsight.com.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.